On December 28, 2023, Abion Inc. closed the transaction
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,005 KRW | -0.17% | +1.52% | -51.69% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7,140 KRW | +0.56% | +5.47% | 114M | ||
3,005 KRW | -0.17% | +1.52% | 31.48M | ||
755 KRW | -1.31% | -0.53% | 61.37M | ||
1st Jan change | Capi. | |
---|---|---|
-51.69% | 31.48M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-5.02% | 1.64B |
- Stock Market
- Equities
- A229000 Stock
- News Gencurix Inc.
- Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.